| Entrar

INFLUÊNCIA DA SÍNDROME METABÓLICA NO AGRAVAMENTO DA COVID-19: UMA REVISÃO NARRATIVA

Doi: 10.47094/IIICNNESP.2022/88

PALAVRAS CHAVE: Obesidade. Coronavírus. Doença crônica não transmissível.

KEYWORDS: Obesity. Coronavirus. Chronic non-communicable disease.

ABSTRACT:
COVID-19, initially identified in China in 2019, corresponds to Severe Acute Respiratory Syndrome (SARS-CoV-2), a clinical condition characterized by lower respiratory tract infection in which affected individuals can present as clinical manifestations ranging from asymptomatic infections to severe forms with risk of life. Several risk groups were identified as more vulnerable because they have a more severe form of the disease, therefore, they have higher mortality, including individuals diagnosed with metabolic syndrome (MS). Metabolic syndrome is a complex disorder characterized by cardiovascular risk factors associated with insulin resistance and central fat deposition. Its origin is attributed to genetic and environmental conditions, inadequate eating habits and physical inactivity, which favor a pro-inflammatory metabolic state (SBC, 2005; SILVA et al. 2021). Thus, this review aims to analyze the scientific literature on the impact of metabolic syndrome on the worsening of patients with COVID-19.

Autores

  • Alessandra Aparecida de Paula

  • Eduarda de Carvalho e Silva da Rosa

  • Isabelle Eduarda Cunha de Freitas

  • Isabely da Silva

  • Isadora Lima Medeiros

  • Mithaly dos Santos Morais

  • Naryelle da Rocha Barbosa

  • Sara de Figueiredo dos Santos

  • Thaynara Dayane Pires Mendes

Download